Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2022.05.11
ag真人平台官方：关于续聘会计师事务所的公告
2022.05.11
ag真人平台官方：关于2021年年度股东大会增加临时提案暨股东大会补充通知的公告
2022.05.11
ag真人平台官方：独立董事关于第五届董事会第十九次会议相关事项之事前认可意见
2022.05.11
ag真人平台官方：独立董事关于第五届董事会第十九次会议相关事项的独立意见
2022.05.11
ag真人平台官方：第五届董事会第十九次会议决议公告
2022.05.10
ag真人平台官方：关于对深圳证券交易所2021年年报问询函回复的公告
2022.04.30
第五届董事会第十八次会议决议公告
2022.04.30
关于董事辞职及财务总监变更的公告
2022.04.30
独立董事关于第五届董事会第十八次会议相关事项的独立意见
2022.04.30
2022年一季度报告
第一页
上一页
12
13
14
15
16
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
